These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8018449)

  • 1. Induction of cytolytic activity of lymphocytes from carcinomatous pleural effusion by IL-2 and autologous tumor cells.
    Sairenji M; Yanoma S; Motohashi H; Kobayashi O; Okada K; Okamoto T; Tsukuda M; Umeda M
    Biotherapy; 1993; 6(4):283-90. PubMed ID: 8018449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
    Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
    Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2.
    Chen YM; Ting CC; Peng JW; Yang WK; Yang KY; Tsai CM; Perng RP
    J Interferon Cytokine Res; 2000 Jan; 20(1):31-9. PubMed ID: 10670650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells].
    Guo Y; Xing Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):80-2, 127. PubMed ID: 7553955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and propagation of tumor-infiltrating lymphocytes from malignant pleural effusion and ascites with engineered cells for costimulatory enhancement.
    Xu Q; Shao J; Su S; Wei J; Chen F; Meng F; Zhao Y; Du J; Zou Z; Qian X; Liu B
    Cell Immunol; 2018 Sep; 331():1-8. PubMed ID: 29903664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: comparison of malignant and tuberculous pleural effusions.
    Chen YM; Tsai CM; Whang-Peng J; Perng RP
    J Interferon Cytokine Res; 2001 Apr; 21(4):249-56. PubMed ID: 11359656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells.
    Guo YS; Xing ZL
    Chin Med J (Engl); 1994 Dec; 107(12):903-5. PubMed ID: 7882727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypes and lymphokine-activated killer activity of pleural cavity lymphocytes of lung cancer patients without malignant effusion.
    Takahashi K; Sone S; Kimura S; Ogura T; Monden Y
    Chest; 1993 Jun; 103(6):1732-8. PubMed ID: 8404092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-interferon enhances the cytotoxic activity of interleukin-2-induced peripheral blood lymphocyte (LAK) cells, tumor infiltrating lymphocytes (TIL), and effusion associated lymphocytes.
    Papamichail M; Baxevanis CN
    J Chemother; 1992 Dec; 4(6):387-93. PubMed ID: 1287141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of killer cells from lymphocytes in pleural effusion of advanced lung cancer patients.
    Inoue Y; Shijubo N; Uede T
    Jpn J Cancer Res; 1990 Oct; 81(10):1012-20. PubMed ID: 2172193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patients.
    Chen YM; Yang WK; Whang-Peng J; Tsai WY; Hung YM; Yang DM; Lin WC; Perng RP; Ting CC
    J Immunother; 1997 Sep; 20(5):354-64. PubMed ID: 9336742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine-activated killer cell activity of peripheral blood, spleen, regional lymph node, and tumor infiltrating lymphocytes in gastric cancer patients.
    Karimine N; Nanbara S; Arinaga S; Asoh T; Ueo H; Akiyoshi T
    J Surg Oncol; 1994 Mar; 55(3):179-85. PubMed ID: 8176929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues.
    Vujanovic NL; Yasumura S; Hirabayashi H; Lin WC; Watkins S; Herberman RB; Whiteside TL
    J Immunol; 1995 Jan; 154(1):281-9. PubMed ID: 7995947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion.
    Hori T; Mise K; Kan N; Okino T; Satoh K; Yamasaki S; Teramura Y; Harada T; Ohgaki K; Kodama H
    Biotherapy; 1992; 5(1):21-9. PubMed ID: 1389900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adoptive immunotherapy and metastasized cancer of the kidney. Regulator effects of interleukin-4 on tumor infiltrating lymphocytes (TIL)].
    Peyret C; Bochner B; Lee TY; Tso CL; Dekernion JB; Belldegrun A
    Chirurgie; 1991; 117(9):700-9. PubMed ID: 1843670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large quantity of CD3-/CD19-/CD16- lymphocytes in malignant pleural effusion from a patient with recurrent cholangio cell carcinoma.
    Onishi H; Morisaki T; Kuga H; Katano M; Doi F; Uchiyama A; Sugitani A; Wada J; Chijiiwa K; Tanaka M
    Immunol Invest; 2002 May; 31(2):121-35. PubMed ID: 12148948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional and phenotypic analysis of tumor infiltrating lymphocytes derived from solid tumors and effusion associated lymphocytes in malignant ascites cultured in recombinant interleukin 2].
    Itoh K; Shiiba K; Ebina N; Anzai R; Ouchi A; Matsuno S
    Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):781-90. PubMed ID: 8377752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of expanded human tumor-infiltrating gammadelta T lymphocytes.
    Chen J; Niu H; He W; Ba D
    Int Arch Allergy Immunol; 2001 Jul; 125(3):256-63. PubMed ID: 11490159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G; Gückel B; Wallwiener D; Moldenhauer G
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.